Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline vs nicotine patch for smoking cessation in hospitalized psychiatric patients
2017-004715-40Phase 4Terminated
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of varenicline in nicotine dependence (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Smoking abstinence efficacy. Started Apr 2018; status: terminated.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2017-004715-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004715-40.